Latest Breaking News On - What are the long term cardiac impacts - Page 1 : vimarsana.com

People Coinfected with SARS-CoV-2 and Cytomegalovirus are at Increased Risk of Developing Cardiovascular Disease

dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.

What We Know About Cardiac Long-COVID Two Years Into the Pandemic

Arrhythmias and chest pain are the frequent presentations, but no signs of long-lasting impacts or spikes in new heart failure cases

Top COVID Content in 2021 Based on What Readers Viewed

COVID-19 Changes Properties Blood Cells

The Long-term Cardiovascular Impact of COVID-19

The Long-term Cardiovascular Impact of COVID-19 Evidence suggests COVID long-haulers may have lingering cardiac impacts from their coronavirus infections Cardiologists are taking a closer look at the possible long-term cardiovascular effects on COVID long-hauler patients who still show symptoms long after they should be recovered from the virus. Getty Images With nearly a year of experience with the COVID-19 (SARS-CoV-2) virus, it has been found that some post-COVID patients experience long-term lingering coughs, cognitive issues and other complains months after they recover from the virus. These long-haulers are also appear to be having the heart issues as well. Determining the long-term impact of coronavirus will certainly be one of the top cardiology issues discussed in 2021.

FDA Approved Second COVID-19 Vaccine From Moderna

FDA Approved Second COVID-19 Vaccine From Moderna The FDA December 18 issued an emergency use authorization (EUA) for a second COVID-19 vaccine from Moderna for use in individuals 18 years of age and older. December 23, 2020 — The U.S. Food and Drug Administration December 18 issued an emergency use authorization (EUA) for a second vaccine for the prevention of coronavirus disease 2019 (COVID-19). The emergency use authorization allows the Moderna COVID-19 Vaccine to be distributed in the U.S. for use in individuals 18 years of age and older. “With the availability of two vaccines now for the prevention of COVID-19, the FDA has taken another crucial step in the fight against this global pandemic that is causing vast numbers of hospitalizations and deaths in the United States each day,” said FDA Commissioner Stephen M. Hahn, M.D.